Scharf Investments, LLC Immunome Inc. Transaction History
Scharf Investments, LLC
- $2.94 Billion
- Q1 2025
A detailed history of Scharf Investments, LLC transactions in Immunome Inc. stock. As of the latest transaction made, Scharf Investments, LLC holds 44,389 shares of IMNM stock, worth $395,949. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,389
Previous 44,389
-0.0%
Holding current value
$395,949
Previous $455,000
34.51%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding IMNM
# of Institutions
149Shares Held
66.4MCall Options Held
47.3KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$67.4 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA5.36MShares$47.8 Million3.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.36MShares$38.9 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$38.4 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$36.4 Million2.16% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $108M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...